PINP: A serum biomarker of bone formation in the rat
Authors:
- L.V. HaleLHL.V. Hale
- R.J. Sells GalvinRGR.J. Sells Galvin
- J. RisteliJRJ. Risteli
- Y.L. MaYMY.L. Ma
- A.K. HarveyAHA.K. Harvey
- X. YangXYX. Yang
- R.L. CainRCR.L. Cain
- Q. ZengQZQ. Zeng
- C.A. FrolikCFC.A. Frolik
- M. SatoMSM. Sato
- A.L. SchmidtASA.L. Schmidt
- A.G. GeiserAGA.G. Geiser
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effects of Teriparatide, Alendronate, or Both on Bone Turnover in Osteoporotic MenThe Journal of Clinical Endocrinology & Metabolism, 2006
- Products of Bone Collagen Metabolism2006
- Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With OsteoporosisJournal of Bone and Mineral Research, 2005
- Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of boneBone, 2004
- Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture riskBone, 2004
- Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density.Scandinavian Journal of Clinical and Laboratory Investigation, 2002
- Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal womenClinical Biochemistry, 2001
- The serum level of the amino‐terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to boneBJU International, 2001
- Components of biological variation of biochemical markers of bone turnover in Paget’s bone diseaseBone, 2000
- Aminoterminal propeptide of type I collagen and bone alkaline phosphatase in the study of bone metastases associated with prostatic carcinomaScandinavian Journal of Clinical and Laboratory Investigation, 1999